Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Iversen

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 10, 1994
Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotideT Skorski, M Nieborowska-Skorska, N C Nicolaides, et al.
Scandinavian Journal of Gastroenterology|January 20, 2021
Clinical efficacy of first and second series of peptide receptor radionuclide therapy in patients with neuroendocrine neoplasm: a cohort studyM D Zacho, P Iversen, G E Villadsen, et al.
International Journal of Oncology|May 6, 2011
Oligonucleotides complementary to c-myb messenger RNA inhibit growth and induce apoptosis in human Burkitt lymphoma cellsS Joshi, A Wu, D Verbik, et al.
European Urology|June 27, 1998
A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancerC J Tyrrell, A V Kaisary, P Iversen, et al.
The Journal of Urology|March 1, 1997
Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer GroupP Iversen, F Rasmussen, C Asmussen, et al.
Urology|October 1, 1989
Ultrasonically guided 125iodine seed implantation with external radiation in management of localized prostatic carcinomaP Iversen, M Bak, N Juul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 studyF B Thomsen, K Brasso, K D Berg, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1989
LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II studyP Iversen, C Rose, J G Stage, et al.
Cancer|September 1, 1990
A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostateP Iversen, M G Christensen, E Friis, et al.
The Journal of Urology|October 12, 2000
Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followupP Iversen, C J Tyrrell, A V Kaisary, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|May 10, 1994
Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotideT Skorski, M Nieborowska-Skorska, N C Nicolaides, et al.
Scandinavian Journal of Gastroenterology|January 20, 2021
Clinical efficacy of first and second series of peptide receptor radionuclide therapy in patients with neuroendocrine neoplasm: a cohort studyM D Zacho, P Iversen, G E Villadsen, et al.
International Journal of Oncology|May 6, 2011
Oligonucleotides complementary to c-myb messenger RNA inhibit growth and induce apoptosis in human Burkitt lymphoma cellsS Joshi, A Wu, D Verbik, et al.
European Urology|June 27, 1998
A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancerC J Tyrrell, A V Kaisary, P Iversen, et al.
The Journal of Urology|March 1, 1997
Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer GroupP Iversen, F Rasmussen, C Asmussen, et al.
Urology|October 1, 1989
Ultrasonically guided 125iodine seed implantation with external radiation in management of localized prostatic carcinomaP Iversen, M Bak, N Juul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 studyF B Thomsen, K Brasso, K D Berg, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1989
LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II studyP Iversen, C Rose, J G Stage, et al.
Cancer|September 1, 1990
A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostateP Iversen, M G Christensen, E Friis, et al.
The Journal of Urology|October 12, 2000
Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followupP Iversen, C J Tyrrell, A V Kaisary, et al.
Pageof 15